3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Cholangiocarcinoma
3
Glioblastoma
2
Upper Tract Urothelial Carcinomas
1
Squamous Cell Carcinoma of Head and Neck
1
Renal Pelvis and Ureter Urothelial Carcinoma
1
Papillomavirus Infections
1
Oncogenic osteomalacia
1
Neoplasm Metastasis
1
Nasopharyngeal Neoplasms
1
Melanoma
1
Hypophosphatemia
1
Hematologic Neoplasms
1
Glioma
1
Breast Neoplasms
1
Advanced Gastrointestinal Stromal Tumor (GIST)
1
Interventions
Sorafenib
23
Bevacizumab
11
Radiosurgery
6
Capecitabine
6
Radiofrequency Ablation
5
Oxaliplatin
5
Fluorouracil
5
Doxorubicin
5
pembrolizumab
4
Sunitinib
4
Erlotinib Hydrochloride
4
Cisplatin
4
Ramucirumab
3
Radiotherapy
3
Nivolumab
3
Leucovorin
3
Carboplatin
3
tremelimumab
2
spartalizumab
2
perflutren
2
derazantinib
2
carotuximab
2
Mitomycin
2
Magnetic Resonance Spectroscopy
2
Magnetic Resonance Imaging
2
Ipilimumab
2
Immunohistochemistry
2
Gemcitabine
2
Folfox protocol
2
Fluorodeoxyglucose F18
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Liver Neoplasms
×
infigratinib
×
Clear all
No trials found.